Cargando…
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review
Many different types of cancer can be treated with immunotherapy drugs called immune checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment options since they function by triggering a stronger immune response to malignancy. As expected, ICIs’ modification of immune...
Autores principales: | Shalata, Walid, Attal, Zoé Gabrielle, Shhadi, Rajeh, Abu Salman, Amjad, Abu Jama, Ashraf, Shalata, Sondos, Halumi, Kais, Yakobson, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673034/ https://www.ncbi.nlm.nih.gov/pubmed/38003995 http://dx.doi.org/10.3390/medicina59111946 |
Ejemplares similares
-
Unexpected and Rare Sites of Metastasis in Oncologic Patients
por: Shalata, Walid, et al.
Publicado: (2023) -
PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
por: Yakobson, Alexander, et al.
Publicado: (2023) -
Associated Myocarditis: A Predictive Factor for Response?
por: Shalata, Walid, et al.
Publicado: (2020) -
Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?
por: Shalata, Walid, et al.
Publicado: (2021) -
Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience
por: Shalata, Walid, et al.
Publicado: (2022)